admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Psychedelic Bulletin #152: Policy and Business Updates

PT470 – Wounded Healers and the Power of Community in the...

Psychedelic Research Bulletin: November 2023

Psychedelic Parenthood: Why are we leaving children and adolescents out of...

Natural Medicine Advisory Bulletin #6: November 2023

PT469 – Drug Policy in 2023: The FDA’s Guidance for Clinical...

Pα+ Psychedelic Bulletin #151: Psilocybin for BDII, ACNP Readouts, Methylone for...

PT468 – Personalized Medicine, Biohacking, and Reconnecting to the Source

BREAKING: MAPS PBC Files New Drug Application for MDMA-Assisted Therapy for...

PT467 – The Role of Religion, Psychedelic Chaplaincy, and Spiritual Care

1...353637...218 Page 36 of 218

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin